These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31666074)

  • 21. Development of the pediatric daily ulcerative colitis signs and symptoms scale (DUCS): qualitative research findings.
    Flood E; Silberg DG; Romero B; Beusterien K; Erder MH; Cuffari C
    BMC Res Notes; 2017 Sep; 10(1):491. PubMed ID: 28946891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring the patient experience of locally advanced or metastatic pancreatic cancer to inform patient-reported outcomes assessment.
    Herman JM; Kitchen H; Degboe A; Aldhouse NVJ; Trigg A; Hodgin M; Narang A; Johnson CD
    Qual Life Res; 2019 Nov; 28(11):2929-2939. PubMed ID: 31273624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Qualitative Research to Understand the Patient Experience and Evaluate Content Validity of the Chronic Ocular Pain Questionnaire (COP-Q).
    Karpecki PM; Findley A; Sloesen BJ; Hodson N; Bentley S; Arbuckle R; O'Brien P; Montecchi-Palmer M; Naujoks C; Hamrah P
    Ophthalmol Ther; 2024 Feb; 13(2):615-633. PubMed ID: 38183618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and content validity of a patient reported outcomes measure to assess symptoms of major depressive disorder.
    Lasch KE; Hassan M; Endicott J; Piault-Luis EC; Locklear J; Fitz-Randolph M; Pathak S; Hwang S; Jernigan K
    BMC Psychiatry; 2012 Apr; 12():34. PubMed ID: 22534028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Qualitative Study to Develop and Evaluate the Content Validity of the Vitiligo Patient Priority Outcome (ViPPO) Measures.
    Kitchen H; Gandhi K; Carmichael C; Wyrwich KW; Lukic T; Al-Zubeidi T; Marshall C; Pegram H; King S; King B
    Dermatol Ther (Heidelb); 2022 Aug; 12(8):1907-1924. PubMed ID: 35857279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A non-interventional observational study to identify and validate clinical outcome assessments for adults with phenylketonuria for use in clinical trials.
    Burton BK; Skalicky A; Baerwald C; Bilder DA; Harding CO; Ilan AB; Jurecki E; Longo N; Madden DT; Sivri HS; Wilcox G; Thomas J; Delaney K
    Mol Genet Metab Rep; 2021 Dec; 29():100810. PubMed ID: 34815941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Qualitative Interviews to Better Understand the Patient Experience and Evaluate Patient-Reported Outcomes (PRO) in RLBP1 Retinitis Pigmentosa (RLBP1 RP).
    Green J; Tolley C; Bentley S; Arbuckle R; Burstedt M; Whelan J; Holopigian K; Stasi K; Sloesen B; Spera C; Deslandes JY; Mullins A
    Adv Ther; 2020 Jun; 37(6):2884-2901. PubMed ID: 32372289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient and caregiver perspective on pediatric eosinophilic esophagitis and newly developed symptom questionnaires*.
    Flood EM; Beusterien KM; Amonkar MM; Jurgensen CH; Dewit OE; Kahl LP; Matza LS
    Curr Med Res Opin; 2008 Dec; 24(12):3369-81. PubMed ID: 19032119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a Novel Tool to Assess the Impact of Itching in Pediatric Cholestasis.
    Kamath BM; Abetz-Webb L; Kennedy C; Hepburn B; Gauthier M; Johnson N; Medendorp S; Dorenbaum A; Todorova L; Shneider BL
    Patient; 2018 Feb; 11(1):69-82. PubMed ID: 28710680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel Questionnaires for Assessing Signs and Symptoms of Eosinophilic Esophagitis in Children.
    Kamat S; Yaworsky A; Guillemin I; Krohe M; Litcher-Kelly L; McLafferty M; Lamoureux RE; Lowe C; Chehade M; Spergel JM; Weinfurt K; Turner-Bowker DM
    J Allergy Clin Immunol Pract; 2022 Jul; 10(7):1856-1863.e3. PubMed ID: 35398552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Severity of Chronic Cough Diary (SCCD): development and content validation of a novel patient-reported outcome instrument for evaluating the symptom experience of chronic cough.
    de la Orden Abad M; Haberland C; Karn H; Skalicky A; Hareendran A
    J Patient Rep Outcomes; 2023 Jul; 7(1):65. PubMed ID: 37428359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Content validity and electronic PRO (ePRO) usability of the Lung Cancer Symptom Scale-Mesothelioma (LCSS-Meso) in mesothelioma patients.
    Gelhorn HL; Skalicky AM; Balantac Z; Eremenco S; Cimms T; Halling K; Hollen PJ; Gralla RJ; Mahoney MC; Sexton C
    Support Care Cancer; 2018 Jul; 26(7):2229-2238. PubMed ID: 29392480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Qualitative Development and Content Validity of the Non-small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ), A Patient-reported Outcome Instrument.
    McCarrier KP; Atkinson TM; DeBusk KP; Liepa AM; Scanlon M; Coons SJ;
    Clin Ther; 2016 Apr; 38(4):794-810. PubMed ID: 27041408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patient-reported Symptoms of Tenosynovial Giant Cell Tumors.
    Gelhorn HL; Tong S; McQuarrie K; Vernon C; Hanlon J; Maclaine G; Lenderking W; Ye X; Speck RM; Lackman RD; Bukata SV; Healey JH; Keedy VL; Anthony SP; Wagner AJ; Von Hoff DD; Singh AS; Becerra CR; Hsu HH; Lin PS; Tap WD
    Clin Ther; 2016 Apr; 38(4):778-93. PubMed ID: 27041409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of the Rheumatoid Arthritis Symptom Questionnaire (RASQ): a patient reported outcome scale for measuring symptoms of rheumatoid arthritis.
    Banderas B; Skup M; Shields AL; Mazar I; Ganguli A
    Curr Med Res Opin; 2017 Sep; 33(9):1643-1651. PubMed ID: 28574727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Qualitative study of patients with venous malformations: symptom experiences and content validity of patient-reported outcome measures.
    England RW; Bailey CR; Anatchkova MD; Skalicky AM; Meissner MH; Rosenblatt M; Gelhorn HL; Weiss CR
    Qual Life Res; 2020 Jun; 29(6):1707-1719. PubMed ID: 32020564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Content Validity of the Hypogonadism Impact of Symptoms Questionnaire (HIS-Q): A Patient-Reported Outcome Measure to Evaluate Symptoms of Hypogonadism.
    Gelhorn HL; Vernon MK; Stewart KD; Miller MG; Brod M; Althof SE; DeRogatis LR; Dobs A; Seftel AD; Revicki DA
    Patient; 2016 Apr; 9(2):181-90. PubMed ID: 26334870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a Clinical Global Impression of Change (CGI-C) and a Caregiver Global Impression of Change (CaGI-C) measure for ambulant individuals with Duchenne muscular dystrophy.
    Staunton H; Trennery C; Arbuckle R; Guridi M; Zhuravleva E; Furlong P; Fischer R; Hall R
    Health Qual Life Outcomes; 2021 Jul; 19(1):184. PubMed ID: 34311756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eliciting the child's voice in adverse event reporting in oncology trials: Cognitive interview findings from the Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events initiative.
    Reeve BB; McFatrich M; Pinheiro LC; Weaver MS; Sung L; Withycombe JS; Baker JN; Mack JW; Waldron MK; Gibson D; Tomlinson D; Freyer DR; Mowbray C; Jacobs S; Palma D; Martens CE; Gold SH; Jackson KD; Hinds PS
    Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27650708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Qualitative development of the 'Questionnaire on Pain caused by Spasticity (QPS),' a pediatric patient-reported outcome for spasticity-related pain in cerebral palsy.
    Geister TL; Quintanar-Solares M; Martin M; Aufhammer S; Asmus F
    Qual Life Res; 2014 Apr; 23(3):887-96. PubMed ID: 24062241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.